Background illustration for clinical trials search

Paid Clinical Trials El Paso

Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

for
Prediabetic State, Atherosclerosis, Metformin
Location: Aurora CO, Albuquerque NM, Salt Lake City UT, Omaha NE,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT02915198

Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Lakewood CO, Salt Lake City UT, Omaha NE,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase 3, Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for
Biochemically Recurrent Prostate Carcinoma,
Location: Lakewood CO, Westminster CO, Longmont CO,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male

Age: 18+

Code: NCT04423211

Phase 3, Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

for
Idiopathic Pulmonary Fibrosis
Location: Lakewood CO, Murray UT, El Paso TX, Hannibal MO,
Sponsor: Trevi Therapeutics

Sex: All

Age: 40+

Code: NCT07671911

Phase 3, Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Lakewood CO, Colorado Springs CO, Albuquerque NM,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

for
Macular Telangiectasia Type 2 (MacTel)
Location: Lakewood CO, Salt Lake City UT, Dallas TX, Houston TX,
Sponsor: Neurotech Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06971939

Recruiting

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

for
Geographic Atrophy (GA)
Location: Lakewood CO, Dallas TX, Austin TX, The Woodlands TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50+

Code: NCT07230834

Phase 1, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Lakewood CO, Longmont CO, Albuquerque NM,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase 2, Recruiting

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

for
Macular Edema
Location: Lakewood CO, Kansas City KS, Southlake TX, Dallas TX,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06962839

Phase 2, Recruiting

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

for
Neovascular (Wet) Age-Related Macular Degeneration
Location: Lakewood CO, Phoenix AZ, Austin TX, Reno NV, Oxnard CA,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT05197270

Phase 1, Phase 2, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Lakewood CO, Salt Lake City UT, Kansas City KS,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase 1, Phase 2, Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

for
Non-Muscle Invasive Bladder Neoplasms
Location: Lakewood CO, Sioux Falls SD, Arlington TX, Dallas TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07309445

Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Neoplasms
Location: Lakewood CO, Sun City AZ, Austin TX, San Antonio TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase 3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Aurora CO, Albuquerque NM, El Paso TX, Des Moines IA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Lakewood CO, Lone Tree CO, Wichita KS, Omaha NE,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase 2, Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Lakewood CO, Colorado Springs CO, Idaho Falls ID,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07415044

Phase 2, Recruiting

Study of WAL0921 in Patients With Glomerular Kidney Diseases

for
Diabetic Nephropathies,
Location: Denver CO, Dakota Dunes SD, San Antonio TX,
Sponsor: Walden Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06466135

Phase 2, Recruiting
New

A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).

for
Diabetic Macular Edema (DME)
Location: Aurora CO, Rapid City SD, Scottsdale AZ, Dallas TX,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 18+

Code: NCT07867080

Phase 3, Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for
Overweight, Obesity
Location: Aurora CO, Albuquerque NM, Sandy City UT, Ogden UT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07282600

Phase 3, Recruiting

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Denver CO, Dallas TX, San Antonio TX, Nashville TN,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07372625

Phase 1, Recruiting